News and blogs

Work in PRogress (2)

We’ve managed to add yet another great new client to our medical portfolio: Ethypharm.

The former CEO of Mallinckrodt Pharmaceuticals, for whom we handled several large international projects in 2014 and 2015, requested that we support his new employer in its international communication and PR efforts as well.

Etypharm specializes in products for pain relief, addiction care and critical care. Although its products are being sold in over 80 countries and the pharmaceutical company has more locations outside Europe than on its home continent, Ethypharm identifies as a ‘European-based speciality pharmaceutical company’. And rightly so, we believe: the strict European rules, Western thoroughness and quality, as well as the patient orientation that is so characteristic of our societies permeate the company.

A number of Worldcom partners will be involved in serving this new client, as was the case with the Mallinckrodt projects.